Bio-Rad Laboratories, Inc. logo
Bio-Rad Laboratories, Inc. (BIO)
Compare

Bio-Rad Laboratories, Inc. (BIO) Free Cash Flow (FCF): $374.60M

The free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO) is $374.60M. It is above its 12-month average by 16.92% ($320.40M).

BIO Free Cash Flow (FCF) Chart

BIO Free Cash Flow (FCF)
$374.60M+40.72% 1Y
Zoom

BIO Average Free Cash Flow (FCF) Chart

BIO Current vs Average Free Cash Flow (FCF) Chart

BIO Free Cash Flow (FCF) Metrics

FREE CASH FLOW (FCF)

$374.60M

FREE CASH FLOW (FCF) AVG TTM

$320.40M

FREE CASH FLOW (FCF) AVG 3Y

$234.84M

FREE CASH FLOW (FCF) AVG 5Y

$325.25M

FREE CASH FLOW (FCF) AVG 10Y

$236.62M

FREE CASH FLOW (FCF) AVG 15Y

$201.01M

FREE CASH FLOW (FCF) AVG 20Y

$182.56M

CURRENT VS TTM AVG

+16.92%

CURRENT VS 3Y AVG

+59.51%

CURRENT VS 5Y AVG

+15.17%

CURRENT VS 10Y AVG

+58.31%

CURRENT VS 15Y AVG

+86.36%

CURRENT VS 20Y AVG

+105.19%

FCF Analysis

Free Cash Flow (TTM)

$374.60M

FCF Yield

4.46%

Price/FCF

22.4

Formula: FCF = Operating Cash Flow - Capital Expenditures

Why FCF matters:

  • Shows actual cash available (not accounting earnings)
  • Funds dividends, buybacks, and debt reduction
  • Less susceptible to accounting manipulation than net income
  • Key metric for DCF valuation models

Bio-Rad Laboratories, Inc. Free Cash Flow (FCF) Formula & Definition

Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Bio-Rad Laboratories, Inc. Free Cash Flow (FCF) FAQ

What is the free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
The free cash flow (FCF) for BIO stock is $374.60M.
What is the TTM average free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
The TTM average free cash flow (FCF) for BIO stock is $320.40M.
What is the 3Y average free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
The 3Y average free cash flow (FCF) for BIO stock is $234.84M.
What is the 5Y average free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
The 5Y average free cash flow (FCF) for BIO stock is $325.25M.
What is the 10Y average free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
The 10Y average free cash flow (FCF) for BIO stock is $236.62M.
What is the 15Y average free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
The 15Y average free cash flow (FCF) for BIO stock is $201.01M.
What is the 20Y average free cash flow (FCF) for Bio-Rad Laboratories, Inc. (BIO)?
The 20Y average free cash flow (FCF) for BIO stock is $182.56M.

Bio-Rad Laboratories, Inc. Free Cash Flow (FCF) History

DATEFREE CASH FLOW (FCF)
2025-12-31$374.60M
2024-12-31$266.20M
2023-12-31$218.26M
2022-12-31$80.29M
2021-12-31$535.72M
2020-12-31$476.41M
2019-12-31$359.37M
2018-12-31$155.67M
2017-12-31$-10.99M
2016-12-31$74.50M
2015-12-31$72.84M
2014-12-31$136.83M
2013-12-31$61.78M
2012-12-31$121.83M
2011-12-31$159.41M
2010-12-31$133.38M
2009-12-31$248.71M
2008-12-31$102.56M
2007-12-31$128.91M
2006-12-31$65.24M
2005-12-31$72.23M
2004-12-31$62.60M
2003-12-31$58.64M
2002-12-31$63.53M
2001-12-31$56.27M
2000-12-31$-7.16M
1999-12-31$-185.10M
1998-12-31$6.10M
1997-12-31$-33.70M
1996-12-31$18.00M

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA
7,700 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Norman D. Schwartz